article thumbnail

Capsida Biotherapeutics Opens New Facility In Thousand Oaks

socalTECH

Thousand Oaks-based biotech company Capsida Biotherapeutics says it has opened up a new, 15,000 square-foot facility in Thousand Oaks for its gene therapy manufacturing efforts. The company says that building its own manufacturing facility will help it eliminate dependence on ontract manufacturing.

article thumbnail

Thousand Oaks Biopharmaceuticals Gets $45M In Series A For Biotech Manufacturing

socalTECH

Thousand Oaks- and Shanghai-based Thousand Oaks Biopharmaceuticals , a new contract manufacturing organization fort he biotech industry, said it has received $45M in a Series A financing round. The company's Chairman is Shun Luo, Ph.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amgen Takes Stake In Chinese Oncology Company

socalTECH

Thousand Oaks-based Amgen said on Thursday afternoon that it has taken a 20.5 percent stake in BeiGene , a research-based, oncology-focused biotechnology company in China. According to Amgen, it paid approximately $2.7 billion in cash for the stake in BeiGene, which it says it will use to expand its oncology presence in China.

article thumbnail

Teledyne Acquires ChartWorld

socalTECH

Thousand Oaks-based Teledyne Technologies said on Tuesday that it has acquired ChartWorld International. The company also has lactions in Hamburg, Singapore, Vancouver and Tokyo. Financial terms of the deal were not announced. ChartWorld is based in Headquarters, and develops digital marine navigation hardware and software.

article thumbnail

Amgen Completes Five Prime Therapeutics Deal

socalTECH

Thousand Oaks-based Amgen said this morning that it has successfully completed its $1.9 billion acquisition of Five Prime Therapeutics, a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies. Amgen paid $38.00 per share in cash for Five Prime Therapeutics.

article thumbnail

Amgen Acquires Teneobio For $900M

socalTECH

Thousand Oaks-based Amgen said on Tuesday that it will pay $900M for Teneobio, a biopharmaceuticals company which is developing treatments for patients with cancer. According to Amgen, the all cash $900M deal also includes future contingent milestone payments worth up to an additional $1.6 billion in cash.

article thumbnail

Dantari Gets $47M For Tumor Medicine Effort

socalTECH

Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases. Markus, M.D., a co-founding managing director at Westlake.